Home Cart Sign in  
Chemical Structure| 54126-45-3 Chemical Structure| 54126-45-3
Chemical Structure| 54126-45-3

3-Chloro-N,N-dimethylpyrazin-2-amine

CAS No.: 54126-45-3

4.5 *For Research Use Only !

Cat. No.: A191497 Purity: 95%

Change View

Size Price

US Stock

Global Stock

In Stock
5g łÇÊó¶ÊÊ Inquiry 1-2 weeks
10g łËÇǶÊÊ Inquiry 1-2 weeks
25g łÍÍó¶ÊÊ Inquiry 1-2 weeks

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 5g

    łÇÊó¶ÊÊ

  • 10g

    łËÇǶÊÊ

  • 25g

    łÍÍó¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 54126-45-3 ]

CAS No. :54126-45-3
Formula : C6H8ClN3
M.W : 157.60
SMILES Code : CN(C)C1=NC=CN=C1Cl
MDL No. :MFCD12827499
InChI Key :OYOQJUBQXIJGFR-UHFFFAOYSA-N
Pubchem ID :20483427

Safety of [ 54126-45-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Calculated chemistry of [ 54126-45-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.33
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 41.25
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

29.02 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.7
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.2
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.2
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.28
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.05
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.09

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.95
Solubility 1.76 mg/ml ; 0.0112 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.41
Solubility 6.19 mg/ml ; 0.0393 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.37
Solubility 0.679 mg/ml ; 0.00431 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.41 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.27

Application In Synthesis [ 54126-45-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 54126-45-3 ]

[ 54126-45-3 ] Synthesis Path-Downstream   1~2

YieldReaction ConditionsOperation in experiment
(2a) 74 g of 2,3-dichloro-pyrazine are added dropwise over the course of 15 minutes, whilst stirring, to 350 ml of a 40% strength aqueous solution of dimethylamine. Whilst doing so, the reaction temperature is kept at 30 C. by cooling. When the exothermic reaction has subsided the mixture is stirred for a further 15 hours at room temperature. The reaction mixture is then extracted by shaking with ether. The ether extracts are washed with water until neutral, dried over sodium sulphate and evaporated in a waterpump vacuum. The residue is distilled in a waterpump vacuum. 2-Chloro-3-dimethylamino-pyrazine, boiling point 100-102 C./10 mm Hg, is thus obtained.
  • 2
  • [ 54126-45-3 ]
  • [ 54126-46-4 ]
YieldReaction ConditionsOperation in experiment
In N,N,N,N,N,N-hexamethylphosphoric triamide; (2S)-N-methyl-1-phenylpropan-2-amine hydrate; (2b) 47 g of <strong>[54126-45-3]2-chloro-3-dimethylamino-pyrazine</strong> and 35 g of allyl alcohol are dissolved in 300 ml of hexamethylphosphoric acid triamide. 14.4 g of sodium hydride are introduced into this solution at 0 C. over the course of 30 minutes. The mixture is then stirred for a further hour at 0 C. and for 15 hours at room temperature. The reaction mixture is then poured into 2 liters of ice water. After excess sodium hydride has been decomposed, the mixture is extracted by shaking with ether. The ether extracts are washed with water until neutral, dried over sodium sulphate and evaporated in a waterpump vacuum. The residue is distilled under reduced pressure. 2-Allyloxy-3-dimethylamino-pyrazine, boiling point 110-115 C./10 mm Hg, is thus obtained.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 54126-45-3 ]

Chlorides

Chemical Structure| 69214-33-1

A466682 [69214-33-1]

8-Chloroimidazo[1,2-a]pyrazine

Similarity: 0.87

Chemical Structure| 6863-73-6

A200064 [6863-73-6]

3-Chloropyrazin-2-amine

Similarity: 0.80

Chemical Structure| 85333-43-3

A202882 [85333-43-3]

8-Chloro-2-methylimidazo[1,2-a]pyrazine

Similarity: 0.75

Chemical Structure| 1208083-37-7

A440728 [1208083-37-7]

6-Bromo-8-chloroimidazo[1,2-a]pyrazine

Similarity: 0.74

Chemical Structure| 143591-61-1

A148216 [143591-61-1]

3-Bromo-8-chloroimidazo[1,2-a]pyrazine

Similarity: 0.73

Amines

Chemical Structure| 6863-73-6

A200064 [6863-73-6]

3-Chloropyrazin-2-amine

Similarity: 0.80

Chemical Structure| 89488-74-4

A297255 [89488-74-4]

2-Amino-3-(dimethylamino)pyrazine

Similarity: 0.67

Chemical Structure| 89182-14-9

A146069 [89182-14-9]

3-Chloro-5-methylpyrazin-2-amine

Similarity: 0.67

Chemical Structure| 89182-15-0

A670346 [89182-15-0]

3-Chloro-6-methylpyrazin-2-amine

Similarity: 0.67

Chemical Structure| 14399-37-2

A173968 [14399-37-2]

3,6-Dichloropyrazin-2-amine

Similarity: 0.66

Related Parent Nucleus of
[ 54126-45-3 ]

Pyrazines

Chemical Structure| 6863-73-6

A200064 [6863-73-6]

3-Chloropyrazin-2-amine

Similarity: 0.80

Chemical Structure| 89488-74-4

A297255 [89488-74-4]

2-Amino-3-(dimethylamino)pyrazine

Similarity: 0.67

Chemical Structure| 89182-14-9

A146069 [89182-14-9]

3-Chloro-5-methylpyrazin-2-amine

Similarity: 0.67

Chemical Structure| 89182-15-0

A670346 [89182-15-0]

3-Chloro-6-methylpyrazin-2-amine

Similarity: 0.67

Chemical Structure| 14399-37-2

A173968 [14399-37-2]

3,6-Dichloropyrazin-2-amine

Similarity: 0.66